PL321630A1 - Application of melantonine for treting patients suffering from drug dependence - Google Patents

Application of melantonine for treting patients suffering from drug dependence

Info

Publication number: PL321630A1
Authority: PL; Poland
Prior art keywords: melantonine; treting; application; patients suffering; drug dependence
Prior art date: 1995-02-01

Application number

PL96321630A

Other versions

PL183148B1 (en

Inventor

Nava Zisapel

Original Assignee

Neurim Pharma 1991

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-01

Filing date

1996-01-29

Publication date

1997-12-08

1995-02-01 Priority claimed from US08/381,535 external-priority patent/US6469044B1/en

1996-01-29 Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991

1997-12-08 Publication of PL321630A1 publication Critical patent/PL321630A1/en

2002-05-31 Publication of PL183148B1 publication Critical patent/PL183148B1/en

Links

206010013663 drug dependence Diseases 0.000 title 1
208000011117 substance-related disease Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Toxicology (AREA)
Anesthesiology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PL96321630A 1995-02-01 1996-01-29 Application of melantonine for treting patients suffering from drug dependence PL183148B1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/381,535 US6469044B1 (en)	1995-02-01	1995-02-01	Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en)	1995-02-01	1995-06-06	Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en)	1995-02-01	1996-01-29	Use of melatonin for treating patients suffering from drug addiction

Publications (2)

Publication Number	Publication Date
PL321630A1 true PL321630A1 (en)	1997-12-08
PL183148B1 PL183148B1 (en)	2002-05-31

Family

ID=26140195

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL96321630A PL183148B1 (en)	1995-02-01	1996-01-29	Application of melantonine for treting patients suffering from drug dependence

Country Status (22)

Country	Link
JP (1)	JP4516159B2 (en)
CN (1)	CN1083263C (en)
AT (1)	AT408188B (en)
AU (1)	AU695366B2 (en)
BG (1)	BG62876B1 (en)
BR (1)	BR9607169A (en)
CZ (1)	CZ291349B6 (en)
DK (1)	DK176081B1 (en)
EE (1)	EE03384B1 (en)
FI (1)	FI119586B (en)
IS (1)	IS1980B (en)
LU (1)	LU90118B1 (en)
LV (1)	LV11940B (en)
MD (1)	MD1716C2 (en)
NO (1)	NO312814B1 (en)
NZ (1)	NZ298878A (en)
PL (1)	PL183148B1 (en)
SI (1)	SI9620022A (en)
SK (1)	SK284521B6 (en)
TR (1)	TR199700723T1 (en)
TW (1)	TW483757B (en)
WO (1)	WO1996023496A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1272177E (en)	2000-01-05	2007-07-11	Neurim Pharma 1991	Method and formulation for treating resistance to antihypertensives and related conditions
IL149377A (en) *	2002-04-28	2012-10-31	Neurim Pharma 1991	Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en)	2003-04-29	2013-12-31	Neurim Pharma 1991	Composition for treating insomnia
US9119846B2 (en)	2003-04-29	2015-09-01	Neurim Pharmaceuticals (1991) Ltd.	Method and composition for enhancing cognition in alzheimer's patients
US11918557B2 (en)	2012-01-26	2024-03-05	Vanda Pharmaceuticals Inc.	Treatment of circadian rhythm disorders
KR102593047B1 (en)	2012-01-26	2023-10-24	반다 파마슈티칼즈, 인코퍼레이티드.	Treatment of circadian rhythm disorders
WO2014100292A1 (en)	2012-12-18	2014-06-26	Vanda Pharmaceuticals Inc.	Treatment of circadian rhythm disorders
US10376487B2 (en)	2013-11-12	2019-08-13	Vanda Pharmaceuticals Inc.	Method of treatment
US11090285B2 (en)	2013-11-12	2021-08-17	Vanda Pharmaceuticals Inc	Treatment of circadian rhythm disorders
SG11201903829PA (en) *	2016-10-31	2019-05-30	Neurim Pharma 1991	Melatonin mini-tablets and method of manufacturing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE181670T1 (en) *	1991-05-09	1999-07-15	Neurim Pharma 1991	MEDICINAL PRODUCTS CONTAINING MELATONIN
IT1251544B (en) *	1991-05-13	1995-05-17	Gabriele Biella	PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE

1996
- 1996-01-29 MD MD97-0254A patent/MD1716C2/en not_active IP Right Cessation
- 1996-01-29 TR TR97/00723T patent/TR199700723T1/en unknown
- 1996-01-29 EE EE9700166A patent/EE03384B1/en not_active IP Right Cessation
- 1996-01-29 AT AT0901396A patent/AT408188B/en not_active IP Right Cessation
- 1996-01-29 SI SI9620022A patent/SI9620022A/en not_active IP Right Cessation
- 1996-01-29 NZ NZ298878A patent/NZ298878A/en not_active IP Right Cessation
- 1996-01-29 JP JP52338596A patent/JP4516159B2/en not_active Expired - Lifetime
- 1996-01-29 BR BR9607169A patent/BR9607169A/en not_active Application Discontinuation
- 1996-01-29 SK SK1030-97A patent/SK284521B6/en unknown
- 1996-01-29 PL PL96321630A patent/PL183148B1/en unknown
- 1996-01-29 CZ CZ19972405A patent/CZ291349B6/en not_active IP Right Cessation
- 1996-01-29 CN CN96191750A patent/CN1083263C/en not_active Expired - Lifetime
- 1996-01-29 WO PCT/IB1996/000082 patent/WO1996023496A1/en not_active Ceased
- 1996-01-29 AU AU44574/96A patent/AU695366B2/en not_active Expired
- 1996-04-12 TW TW085104319A patent/TW483757B/en not_active IP Right Cessation
1997
- 1997-07-24 LV LVP-97-144A patent/LV11940B/en unknown
- 1997-07-25 IS IS4532A patent/IS1980B/en unknown
- 1997-07-30 DK DK199700896A patent/DK176081B1/en not_active IP Right Cessation
- 1997-07-30 BG BG101803A patent/BG62876B1/en unknown
- 1997-07-31 NO NO19973531A patent/NO312814B1/en not_active IP Right Cessation
- 1997-07-31 FI FI973185A patent/FI119586B/en not_active IP Right Cessation
- 1997-08-01 LU LU90118A patent/LU90118B1/en active

Also Published As

Publication number	Publication date
NO312814B1 (en)	2002-07-08
AT408188B (en)	2001-09-25
FI973185L (en)	1997-09-30
NZ298878A (en)	1999-05-28
DK176081B1 (en)	2006-04-18
IS1980B (en)	2005-01-14
MD1716C2 (en)	2002-02-28
IS4532A (en)	1997-07-25
MD1716B2 (en)	2001-08-31
MX9705856A (en)	1998-07-31
FI119586B (en)	2009-01-15
NO973531L (en)	1997-09-30
SI9620022A (en)	1998-10-31
CZ291349B6 (en)	2003-02-12
WO1996023496A1 (en)	1996-08-08
LU90118B1 (en)	1997-11-13
SK284521B6 (en)	2005-05-05
LV11940A (en)	1998-01-20
BR9607169A (en)	1997-11-11
JP4516159B2 (en)	2010-08-04
PL183148B1 (en)	2002-05-31
CN1083263C (en)	2002-04-24
TR199700723T1 (en)	1998-02-21
EE03384B1 (en)	2001-04-16
TW483757B (en)	2002-04-21
JPH10513177A (en)	1998-12-15
SK103097A3 (en)	1998-01-14
LV11940B (en)	1998-05-20
CN1172431A (en)	1998-02-04
AU695366B2 (en)	1998-08-13
FI973185A0 (en)	1997-07-31
BG101803A (en)	1998-04-30
ATA901396A (en)	2001-02-15
EE9700166A (en)	1998-02-16
DK89697A (en)	1997-07-30
BG62876B1 (en)	2000-10-31
AU4457496A (en)	1996-08-21
MD970254A (en)	1999-05-31
CZ240597A3 (en)	1998-01-14
NO973531D0 (en)	1997-07-31

Publication	Publication Date	Title
AU5178296A (en)	1996-09-11	Induction of e-selectin for targetting therapeutic agents
HRP960300B1 (en)	2000-10-31	Inhaler for administration of blister-packed medicaments
GB2303064B (en)	1999-10-06	Medicament for nasal administration
HUP9601698A3 (en)	2000-09-28	Pharmaceutical composition of adiabetical activity
AU7070596A (en)	1997-04-01	Transdermal administration of olanzapine
AU9028798A (en)	1999-03-16	Method of improving drug treatment
IL117957A0 (en)	1996-08-04	Pharmaceutical compositions for the treatment of impotence
AU6094996A (en)	1996-12-30	Diphosphonate derivatives of therapeutic agents
HUP9901089A3 (en)	2000-03-28	Medical splint
AUPO727097A0 (en)	1997-07-03	Method of treatment of hepatoma and pharmaceutical compositions for use therein
AU4078997A (en)	1998-03-06	Cholinesterase inhibitors for treatment of parkinson's disease
HUP9900751A3 (en)	2000-07-28	Stable pharmaceutical forms of administration containing parathormone
AU5965696A (en)	1996-12-24	Terpenoid-type quinones for treatment of diabetes
AU2939897A (en)	1997-12-05	Administration of histamine for therapeutic purposes
PL321630A1 (en)	1997-12-08	Application of melantonine for treting patients suffering from drug dependence
AU7042796A (en)	1997-05-01	Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
EP0713691A3 (en)	1996-11-20	Aid for supporting body parts of patients
GB9700737D0 (en)	1997-03-05	Administration of drugs
AU8869398A (en)	1999-03-16	Medical apparatus for relief of pain
HU9502426D0 (en)	1995-10-30	Compounds of pharmaceutical activity
HUP9901303A3 (en)	2001-04-28	A pharmaceutical composition for the treatment of autoimmune diseases
GB9525918D0 (en)	1996-02-21	Structure of armrest-driven wheelchair
SI0871616T1 (en)	2002-12-31	Process for the preparation of anti-malarial drugs
AU5713196A (en)	1996-11-07	Method for treatment of pain
AU6171196A (en)	1996-12-30	Therapeutic uses of ta99